BiotechTube
Home/BCN Biosciences/Sudip Chakrabortty
SC

Sudip Chakrabortty

Co-founder & CEO

BCN Biosciences

Therapeutic Areas

Oncology

BCN Biosciences Pipeline

DrugIndicationPhase
RAS Pathway Inhibitor (PTEN restoration)KRAS-mutant cancers (G12D, G12V variants)Preclinical
PD-1 Expression InhibitorImmuno-oncologyPreclinical

Leadership Team at BCN Biosciences

AJ
Andrew J. Norris
Co-founder & Director of Research
View full BCN Biosciences profile